Ancora Advisors’s VSee Health VSEE Stock Holding History

Ancora Advisors’s Portfolio VSEE Stock Details VSEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400	Closed	-$4K	–	2356
2022 Q1	$4K	Buy	+400	New	+$3.98K	﹤0.01%	2022

Other funds holding VSEE

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Ancora Advisors's VSEE Position: Q2 2022 in Review

Ancora Advisors sold out of VSee Health (VSEE) in Q2 2022, closing a stake of 400 shares — an estimated $4K sold.

Ancora Advisors first reported a position in VSEE in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 37 funds tracked by Wall St. Rank hold VSEE as of Q2 2022.

Ancora Advisors reported no remaining VSee Health position as of Q2 2022 after selling out during the quarter.
Ancora Advisors sold 400 VSee Health shares in Q2 2022, an estimated $4K.
Ancora Advisors first reported a position in VSee Health in Q1 2022 and held it in 1 quarter.
Ancora Advisors's VSee Health position peaked at $4K in Q1 2022.
37 funds tracked by Wall St. Rank held VSee Health as of Q2 2022.

Based on Ancora Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.